Bioxytran, Inc.

BIXT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B4 Feb 18, 2025
EFFECT Feb 14, 2025
CORRESP Feb 12, 2025
CORRESP Feb 12, 2025
S-1/A Feb 12, 2025
S-1/A Feb 5, 2025
UPLOAD Feb 4, 2025
DEL AM Jan 23, 2025
S-1 Jan 22, 2025
8-K Jan 22, 2025
4 Jan 14, 2025 PRIMARY DOCUMENT
4 Jan 14, 2025 PRIMARY DOCUMENT
4 Jan 14, 2025 PRIMARY DOCUMENT
4 Jan 14, 2025 PRIMARY DOCUMENT
8-K Jan 13, 2025
10-K/A Jan 13, 2025
8-K Jan 10, 2025
10-Q Oct 29, 2024
8-K Oct 29, 2024
4 Oct 28, 2024 PRIMARY DOCUMENT
4 Oct 28, 2024 PRIMARY DOCUMENT
4 Oct 28, 2024 PRIMARY DOCUMENT
4 Oct 28, 2024 PRIMARY DOCUMENT
4 Oct 28, 2024 PRIMARY DOCUMENT
4 Oct 28, 2024 PRIMARY DOCUMENT
← Newer Page 2 of 19 · 469 filings Older →